On June 21, 2024 BCI Pharma reported that the company has been acquired by Gedeon Richter (Press release, BCI Pharma, JUN 21, 2024, View Source [SID1234644488]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Dominique Surleraux, former BCI Pharma CEO, said : "This acquisition will ensure the continuity and development of the BCI and also further clinical development of our assets/research projects. I would like to take the opportunity to thank BCI scientists for their input, BCI investors and the Belgium Walloon region Ministry of economic (SPW wallonie) for their financial support. I’m pretty confident that our assets will improve the quality of life of patients suffering from cancer and endometriosis."